Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Blood|September 16, 2017
Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpuraMarie Scully, Paul Knöbl, Karim Kentouche, et al.
Research and Practice in Thrombosis and Haemostasis|April 1, 2024
Long-term outcomes with emicizumab in hemophilia A without inhibitors: results from the HAVEN 3 and 4 studiesJohnny Mahlangu, Víctor Jiménez-Yuste, Giuliana Ventriglia, et al.
Blood|December 18, 2012
Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patientsShawn F J Whelan, Christoph J Hofbauer, Frank M Horling, et al.
Advances in Respiratory Medicine|July 24, 2026
Guidelines for Minimizing Bleeding Risk During Bronchoscopic ProceduresAdam Barczyk, Anna Andrychiewicz, Małgorzata Czajkowska-Malinowska, et al.
American Journal of Hematology|April 27, 2018
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trialsJames Bussel, Donald M Arnold, Elliot Grossbard, et al.
European Journal of Haematology|July 20, 2024
Disease and treatment burden of patients with haemophilia entering the explorer6 non-interventional studyJerzy Windyga, Shashikant Apte, Melissa Frei-Jones, et al.
The New England Journal of Medicine|July 11, 2017
Emicizumab Prophylaxis in Hemophilia A with InhibitorsJohannes Oldenburg, Johnny N Mahlangu, Benjamin Kim, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 15, 2018
The effect of emicizumab prophylaxis on health-related outcomes in persons with haemophilia A with inhibitors: HAVEN 1 StudyJohannes Oldenburg, Johnny N Mahlangu, Willem Bujan, et al.
Blood Advances|June 24, 2026
Concizumab in patients with hemophilia A or B without inhibitors: 56-week cut-off results of the phase 3 explorer8 studyGuy Young, Pantep Angchaisuksiri, Shashikant J Apte, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 5, 2025
Real-World Unmet Needs of Patients With Haemophilia A and Haemophilia B With or Without Inhibitors: End-of-Study Results From the explorer6 Non-Interventional StudyAllison P Wheeler, Aby Abraham, Chris Barnes, et al.
Pageof 10